Evidence map›Paper›PMID 36860726›Full record

ArticleClinical case reports2023

Linear IgA bullous dermatosis and elevated bullous interleukin-6 levels: Responsive to treatment with Anti-IL-6 receptor monoclonals.

Stanley C Jordan, Bonnie Balzer, Cynthia Nast, Janet Atienza, Katherine Lim, Sanjeev Kumar, Nicholas Nissen, Bongha Shin

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Stanley C JordanComprehensive Transplant Center Cedars-Sinai Medical Center Los Angeles California USA.ORCID https://orcid.org/0000-0002-0456-8635
Bonnie BalzerDepartment of Pathology & Laboratory Medicine Cedars-Sinai Medical Center Los Angeles California USA.
Cynthia NastDepartment of Pathology & Laboratory Medicine Cedars-Sinai Medical Center Los Angeles California USA.
Janet AtienzaComprehensive Transplant Center Cedars-Sinai Medical Center Los Angeles California USA.
Katherine LimComprehensive Transplant Center Cedars-Sinai Medical Center Los Angeles California USA.
Sanjeev KumarComprehensive Transplant Center Cedars-Sinai Medical Center Los Angeles California USA.
Nicholas NissenComprehensive Transplant Center Cedars-Sinai Medical Center Los Angeles California USA.
Bongha ShinComprehensive Transplant Center Cedars-Sinai Medical Center Los Angeles California USA.
Cedars-Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linear IgA bullous dermatosis (LABD) is  a rare autoimmune/inflammatory skin condition. Here, we report on a patient who developed treatment resistant LABD. At diagnosis, elevations of IL-6 and C-reactive protein in the blood and extreme elevations of IL-6 in LABD bullous fluid were seen. The patient responded well to tocilizumab (anti-IL-6 receptor) treatment.

Indexed as

anti‐IL‐6 receptor antibodyIgA bullous dermatosisinterleukin 6kidney transplantpancreatic cancer

Identifiers

PMID36860726
PMCPMC9969760
OpenAlexW4322505188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.